Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
DFE Pharma
DFE Pharma
Activities:
Ingredients
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
DFE Pharma opens Indian OSD-focused pharma support centre
The company has planned to provide services that are mainly focus on oral solid dosage (OSD) forms and comprise a range of pre-registration work including development, scale-up, and technology transfer
Ingredients
DFE Pharma expands its inhalation portfolio with the launch of Lactohale 400
Being a leader in dry powder inhalation, DFE Pharma further expands its broad excipient portfolio of inhalation grade lactose
Ingredients
DFE Pharma opens its new centre of excellence in India to provide fast-track formulation services
The new Closer to the Formulator (C2F) centre offers DFE Pharma’s excipient expertise to help pharmaceutical companies achieve right-first-time formulations
Manufacturing
Manufacturing Chemist LIVE 2022 in review (part I)
Taking a front row seat during the two-day pharmaceutical conference in Birmingham, UK, Dr Kevin Robinson reports on what’s new, emerging and exciting in the world of drug delivery and beyond
Manufacturing
Manufacturing Chemist LIVE announces NEPIC as an event partner
NEPIC members are invited to attend or exhibit at this year's event at a discounted rate.
Ingredients
DFE Pharma appoints Chief Executive Officer
Martti Hedman joins from Colorcon, where he was also CEO
Ingredients
DMV-Fonterra to buy Brahmar Cellulose Private Limited
Provides a strong base for future developments
Subscribe now